GURU.Markets stock price, segment price, and overall market index valuation
The company's share price RxSight Inc.
RxSight is a manufacturer of unique intraocular lenses that can be corrected after cataract surgery. Its stock price reflects the introduction of this revolutionary technology. Its chart is a growth story driven by the changing standard of care in ophthalmology.
Share prices of companies in the market segment - Specialized medical equipment
RxSight revolutionized cataract surgery by creating the first intraocular lens whose light power can be adjusted postoperatively. We've classified the company in the "Specialized Medical Equipment" segment. The chart below shows the overall dynamics of this innovative sector, where breakthrough technologies can radically change treatment standards.
Broad Market Index - GURU.Markets
RxSight has developed unique intraocular lenses that can be adjusted after cataract surgery to achieve perfect vision. As part of the GURU.Markets index, it is revolutionizing ophthalmology. The chart below represents the entire market. See how RxSight shares compare to the overall trend.
Change in the price of a company, segment, and market as a whole per day
RXST - Daily change in the company's share price RxSight Inc.
The volatility of RxSight, a developer of intraocular lenses, reflects innovation in ophthalmology. Change_co reflects sensitivity to technology adoption by surgeons and regulatory approvals. This metric is key to analyzing the medical device sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Specialized medical equipment
RxSight, Inc. is a company in the medical device sector. This chart illustrates the high volatility of the MedTech industry. Comparing it to RXST, which focuses on intraocular lenses, helps assess whether its innovative products make it more or less volatile than the sector.
Daily change in the price of a broad market stock, index - GURU.Markets
RxSight is a manufacturer of innovative intraocular lenses that can be adjusted after cataract surgery. The medical technology market is growing rapidly. The chart below shows the volatility in this sector, helping to assess how RxSight shares are responding to innovation.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization RxSight Inc.
RxSight, Inc.'s year-over-year performance is a story of the introduction of its unique intraocular lens technology, which can be corrected after cataract surgery. Its 12-month market capitalization growth reflects the growing number of ophthalmology clinics using this technology, fundamentally changing the approach to achieving perfect vision for patients.
Annual dynamics of market capitalization of the market segment - Specialized medical equipment
RxSight, Inc. has revolutionized cataract surgery with its intraocular lenses, which can be adjusted postoperatively. Its rapid growth is fueled by the adoption of its technology by surgeons. The chart below shows how its innovative product and dominant market position allow it to significantly outpace the industry.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
RxSight, with its unique adjustable eye lenses, is a growth story in medicine. Its stock price is driven not by the economy, but by the speed of technology adoption by surgeons. The chart illustrates how a breakthrough technology can gain market share in the conservative but vast ophthalmology market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization RxSight Inc.
RxSight, a manufacturer of intraocular lenses, is seeing growth driven by the adoption of its technology. Monthly fluctuations on the chart reflect the growth in cataract procedures performed using its unique lenses, which allow for post-operative vision correction, a key indicator of its growth.
Monthly dynamics of market capitalization of the market segment - Specialized medical equipment
RxSight, Inc. has developed the first and only intraocular lens (IOL) whose curvature can be corrected after cataract surgery using ultraviolet light. The dynamics of its sector, shown in the graph, reflect innovation in medicine. Against this backdrop, one can appreciate how its revolutionary technology is changing the expectations of patients and ophthalmologists.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
RxSight, a manufacturer of intraocular lenses, operates in the elective medical procedures market. Demand for its products depends on household incomes and their willingness to spend on health. The chart shows how the company's shares respond to changes in consumer confidence, making them sensitive to general economic cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization RxSight Inc.
RxSight has developed intraocular lenses that can be adjusted after cataract surgery. Its weekly stock price reflects the pace of adoption of this breakthrough technology by ophthalmologists and its commercial success.
Weekly dynamics of market capitalization of the market segment - Specialized medical equipment
RxSight, like other companies in the innovative medical equipment sector, is dependent on general factors such as the pace of adoption of new technologies in hospitals and insurance policies. The chart compares the company's performance with the overall health of its medical sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
RxSight, Inc. is a medical technology company with an innovative cataract surgery technology. Its success depends on the implementation of this method. The chart will show how independent the company's shares are from the broader market, moving in sync with their own performance rather than market volatility.
Market capitalization of the company, segment and market as a whole
RXST - Market capitalization of the company RxSight Inc.
RxSight, Inc.'s chart tells the story of innovation in cataract surgery. Its market capitalization reflects how the market values its unique light-adjustable lens technology, which allows for vision adjustment after surgery. It's a bet on a new standard in ophthalmology.
RXST - Share of the company's market capitalization RxSight Inc. within the market segment - Specialized medical equipment
RxSight, Inc. revolutionized cataract surgery, capturing market share with its light-adjustable lenses. Its market cap reflects its unique technology, which allows for the patient's vision to be customized postoperatively.
Market capitalization of the market segment - Specialized medical equipment
RxSight has created a lens that can be adjusted after surgery. What is the scale of this revolution? The chart below shows the overall market capitalization of the specialized equipment sector. Its growth reflects how innovations can radically change treatment standards and improve the quality of life for millions of patients.
Market capitalization of all companies included in a broad market index - GURU.Markets
The RxSight chart shows how the market values innovations in cataract surgery. The market cap of the company, which created intraocular lenses that can be customized post-surgery, reflects its belief in its ability to change the standard of treatment. This diagram illustrates how personalization is coming to ophthalmology.
Book value capitalization of the company, segment and market as a whole
RXST - Book value capitalization of the company RxSight Inc.
RxSight's assets include its manufacturing facilities for creating unique intraocular lenses that can be adjusted after surgery, as well as its R&D centers. Its book value reflects the value of these high-tech medical assets. The chart below shows how the value of this production capital has grown.
RXST - Share of the company's book capitalization RxSight Inc. within the market segment - Specialized medical equipment
RxSight, Inc. is revolutionizing cataract surgery. Its tangible assets include manufacturing facilities that create unique intraocular lenses that can be customized post-operatively. The chart shows the company's control over this cutting-edge ophthalmological manufacturing infrastructure.
Market segment balance sheet capitalization - Specialized medical equipment
RxSight produces intraocular lenses. The medical equipment sector, as the chart shows, is capital-intensive. RxSight is an innovator. Its business consists of R&D and factories that produce unique lenses whose optical power can be adjusted after surgery.
Book value of all companies included in the broad market index - GURU.Markets
RxSight's core competencies include manufacturing facilities for creating unique intraocular lenses that can be customized post-surgery. The chart shows how the company has expanded its resources to produce this breakthrough technology.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - RxSight Inc.
RxSight owns manufacturing facilities. The market is paying a premium for their revolutionary customizable lens technology. The chart below shows how the market perceived their ability to change the standard in ophthalmology.
Market to book capitalization ratio in a market segment - Specialized medical equipment
RxSight has developed lenses that can be adjusted after cataract surgery. Its value lies in this breakthrough technology. The chart shows a high market valuation premium over book value, reflecting the potential to transform ophthalmic surgery.
Market to book capitalization ratio for the market as a whole
RxSight has developed unique intraocular lenses whose optical power can be adjusted after cataract surgery. Its valuation, unlike the average in this chart, is based on its disruptive technology. The market is evaluating its potential to change the standard of care and its business model, which includes recurring revenue from correction procedures.
Debts of the company, segment and market as a whole
RXST - Company debts RxSight Inc.
RxSight has developed unique intraocular lenses that can be adjusted after cataract surgery. This chart shows how the company is funding its rapid commercial growth. The capital raised is being used to expand its sales force and deploy its equipment in ophthalmology clinics.
Market segment debts - Specialized medical equipment
RxSight has developed and commercialized a unique intraocular lens whose light sensitivity can be adjusted after cataract surgery. This chart shows how the company's leverage, while in active growth, reflects its investment in marketing and surgeon training to promote this innovative technology in the ophthalmology market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio RxSight Inc.
RxSight is a medical company that has developed unique intraocular lenses that can be adjusted after cataract surgery. This chart shows how the company uses debt to commercialize its innovative technology, including marketing and surgeon training, which are key to assessing its financial risk.
Market segment debt to market segment book capitalization - Specialized medical equipment
RxSight has developed a cataract implantable lens that can be adjusted post-surgery. This chart shows the debt burden in the specialized medical device sector. It helps understand how the company is funding the commercialization of its unique and breakthrough technology in the ophthalmology market.
Debt to book value of all companies in the market
RxSight, Inc. offers unique intraocular lenses that can be adjusted after cataract surgery. Introducing such innovative technology requires significant marketing expenditures. This graph of total market debt helps us understand how the company is funding its product's commercialization. Is it using debt to accelerate market penetration?
P/E of the company, segment and market as a whole
P/E - RxSight Inc.
RxSight has developed and commercialized a unique intraocular lens (IOL), a light-controlled lens that allows surgeons to precisely adjust a patient's vision after cataract surgery. This chart shows how investors view this breakthrough ophthalmological technology. The dynamics depend on the pace of its adoption by surgeons.
P/E of the market segment - Specialized medical equipment
RxSight developed and commercialized the first and only intraocular lens (artificial lens) whose parameters can be adjusted after cataract surgery using ultraviolet light. This chart shows the average rating for the specialized medical equipment sector, reflecting how the market values breakthrough technologies that personalize surgery.
P/E of the market as a whole
RxSight is a medical technology company that has developed intraocular lenses that can be adjusted after cataract surgery. Its growth depends on surgeons adopting this premium technology. Its business is driven by innovation in ophthalmology, not by the general economic cycles reflected in this chart.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company RxSight Inc.
RxSight, Inc. has developed the first and only intraocular lens (IOL) whose curvature can be adjusted after cataract surgery using ultraviolet light. This chart reflects the expectations for this breakthrough technology in ophthalmology. The company's valuation is a bet that its light-adjustable lenses will become the new standard.
%20P%2FE%20RxSight%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-RxSight-Inc.&v=1772574477869 "Chart of the company's future (projected) P/E RxSight Inc.")
Future (projected) P/E of the market segment - Specialized medical equipment
RxSight has developed the first and only intraocular lens whose optical power can be adjusted after cataract surgery using ultraviolet light. This chart reflects expectations for this revolutionary technology. Comparing these forecasts to the sector reveals the premium investors are paying for its unique and patented product.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Specialized-medical-equipment&v=1772574477965 "Future (projected) P/E graph of the market segment - Specialized medical equipment")
Future (projected) P/E of the market as a whole
RxSight developed the first and only intraocular lens whose visual acuity can be adjusted after cataract surgery. This is a breakthrough technology in ophthalmology. Against the backdrop of general market cycles, as illustrated by this chart, RxSight's story is a bet that its technology will become the new standard in cataract surgery.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772574478006 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit RxSight Inc.
RxSight, Inc. is a medical technology company that has developed intraocular lenses whose curvature can be corrected after cataract surgery. Revenue depends on sales of these lenses and equipment to ophthalmologists. This chart shows the commercialization of an innovative product in the large and growing field of ophthalmology.
Profit of companies in the market segment - Specialized medical equipment
RxSight, Inc. has developed a unique intraocular lens (artificial lens) technology that can be adjusted after cataract surgery using ultraviolet light. The profitability chart for the specialized medical equipment sector demonstrates how such breakthrough technologies, offering personalization and improved results, can change the standards in ophthalmology.
Overall market profit
RxSight has developed and commercialized the first and only intraocular lens whose curvature can be corrected after cataract surgery. This is a breakthrough technology in ophthalmology. The company's growth depends on its adoption by surgeons and demonstrates how innovations in medical devices can significantly improve treatment outcomes.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company RxSight Inc.
RxSight has developed a unique, light-controlled intraocular lens that can be adjusted after cataract surgery. This graph shows the expected commercialization of this breakthrough technology. Revenue depends on its acceptance by surgeons and patients.
%20profit%20of%20the%20company%20RxSight%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-RxSight-Inc.&v=1772574478211 "Graph of future (projected) profit of the company RxSight Inc.")
Future (predicted) profit of companies in the market segment - Specialized medical equipment
RxSight, Inc. has developed the first and only intraocular lens capable of correcting visual acuity after cataract surgery. This graph shows projected revenue trends for the ophthalmology equipment sector. It allows one to assess how this breakthrough technology is changing treatment standards and its growth prospects.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Specialized-medical-equipment&v=1772574478213 "Graph of future (predicted) profits of companies in a market segment - Specialized medical equipment")
Future (predicted) profit of the market as a whole
The trajectory on this chart shows the expectations for the intraocular lens manufacturer. RxSight's profit forecast hinges on the adoption of its unique light-controlled lens technology, which allows for vision correction after cataract surgery. Adoption of this technology by surgeons and patients is key to growth.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772574478246 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - RxSight Inc.
RxSight has developed unique intraocular lenses that can be adjusted after cataract surgery. This chart shows the premium investors are paying for its growing revenue. The multiple reflects the potential of its technology to become a new standard in ophthalmology.
P/S market segment - Specialized medical equipment
RxSight has developed the first and only intraocular lens whose curvature can be corrected after cataract surgery using ultraviolet light. Revenue depends on the adoption of this technology. This chart shows the average valuation in the sector, reflecting how highly the market values this breakthrough technology and its revenue-generating potential.
P/S of the market as a whole
RxSight has developed the first and only intraocular lens whose curvature can be corrected after cataract surgery using ultraviolet light. This breakthrough technology is groundbreaking. This graph, which reflects RxSight's average revenue estimate, helps us understand how the market values medical innovations that have the potential to radically change treatment standards.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company RxSight Inc.
RxSight has developed a lens that can be customized after cataract surgery to achieve perfect vision. The company's future revenue depends on the adoption of this premium technology by ophthalmologists. This chart shows how investors assess the potential of this innovative product in the vast cataract surgery market.
%20P%2FS%20RxSight%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-RxSight-Inc.&v=1772574478402 "The graph of the company's future (projected) P/S RxSight Inc.")
Future (projected) P/S of the market segment - Specialized medical equipment
RxSight has developed the first and only intraocular lens that can be adjusted after cataract surgery. This chart compares the company's estimated future sales with other medical device manufacturers. It reflects investor expectations for this breakthrough technology, which enables perfect vision.
%20P%2FS%20market%20segment%20graph%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Specialized-medical-equipment&v=1772574478451 "Future (projected) P/S market segment graph - Specialized medical equipment")
Future (projected) P/S of the market as a whole
RxSight has developed an intraocular lens whose optical power can be adjusted after implantation during cataract surgery. The company's growth depends on the adoption of this innovative technology by ophthalmologists. RxSight's success exemplifies how technology can improve treatment outcomes and create new standards in medicine.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772574478543 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales RxSight Inc.
RxSight, Inc. has developed a unique intraocular lens technology that can be adjusted after cataract surgery to achieve perfect vision. This chart shows revenue from sales of these lenses and related equipment, reflecting the adoption of this breakthrough technology in ophthalmology.
Sales of companies in the market segment - Specialized medical equipment
RxSight, Inc. has developed the first and only intraocular lens (IOL) system that can be adjusted after cataract surgery to precisely tailor vision. This chart shows overall sales in the medical device market, illustrating how breakthrough technologies can dramatically improve the results of standard surgical procedures and create a new standard of care.
Overall market sales
RxSight has developed and commercialized the first and only intraocular lens whose light sensitivity can be adjusted after cataract surgery. This overall economic activity impacts RxSight through healthcare costs. The aging demographic trend creates demand, and a healthy economy ensures solvency.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company RxSight Inc.
RxSight has developed unique intraocular lenses (IOLs) that can be adjusted after cataract surgery to achieve perfect vision. This chart shows analysts' forecasts for the adoption of this revolutionary technology in ophthalmological practice and the growth in the number of procedures using RxSight lenses.
%20sales%20of%20the%20company%20RxSight%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-RxSight-Inc.&v=1772574478696 "Schedule of future (projected) sales of the company RxSight Inc.")
Future (projected) sales of companies in the market segment - Specialized medical equipment
RxSight, Inc. has developed an intraocular lens whose curvature can be adjusted after cataract surgery. This chart shows projected revenues for the entire medical device sector. While it reflects general trends, what's more important for RxSight is the speed of surgeon adoption of its unique Light Adjustable Lens technology.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Specialized-medical-equipment&v=1772574478731 "Schedule of future (projected) sales of companies in the market segment - Specialized medical equipment")
Future (projected) sales of the market as a whole
RxSight has developed an intraocular lens whose curvature can be corrected after cataract surgery. Demand for its innovative product depends on the willingness of surgeons and patients to pay for premium technology. This indicator, reflecting consumer confidence, is important to the company. During periods of economic growth, people are more willing to choose more expensive and advanced medical solutions.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772574478754 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality RxSight Inc.
RxSight has developed a unique technology—intraocular lenses that can be adjusted after cataract surgery. This graph shows the innovator's financial trajectory. Profitability depends on convincing surgeons and patients of the benefits of its premium technology, which requires significant marketing expenditures.
Market segment marginality - Specialized medical equipment
RxSight has developed a unique intraocular lens technology that can be adjusted after cataract surgery. This represents a breakthrough in ophthalmology. This chart shows the company's operational structure during the commercialization phase. It reflects the costs of bringing this innovative technology to market and competition with traditional lens manufacturers.
Market marginality as a whole
RxSight has developed the first and only light-adjustable intraocular lens (IOL) that allows for vision adjustment after cataract surgery. The company's profitability depends on the adoption of this breakthrough technology by ophthalmic surgeons. This total market return chart highlights how RxSight can change the standard of cataract treatment and establish a unique market position.
Employees in the company, segment and market as a whole
Number of employees in the company RxSight Inc.
RxSight has developed unique intraocular lenses that can be adjusted after cataract surgery. This chart shows the growth of the commercial team. The increase in staff is directly related to the commercialization of this revolutionary technology and the training of ophthalmic surgeons to use it.
Share of the company's employees RxSight Inc. within the market segment - Specialized medical equipment
This figure reflects the innovative approach of RxSight, Inc. The company's medical device sector is focused on commercializing its light-adjustable lens system for cataract surgery. This team offers a unique technology that allows doctors to precisely adjust a patient's vision after implantation of an artificial lens.
Number of employees in the market segment - Specialized medical equipment
RxSight, Inc. has developed a unique technology—an intraocular lens whose curvature can be corrected using light after implantation during cataract surgery. This graphic illustrates how breakthrough ophthalmological technologies are changing treatment standards and requiring surgeons to master new equipment and techniques.
Number of employees in the market as a whole
RxSight, Inc. has developed intraocular lenses that can be adjusted after cataract surgery. Demand for its products is driven by the demographics of an aging population. This employment situation has an indirect impact: stable employment provides patients with access to the best medical technologies through insurance.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company RxSight Inc. (RXST)
RxSight has developed intraocular lenses whose curvature can be corrected after cataract surgery. This chart shows how the market values this breakthrough medical technology. The very high market capitalization per employee suggests that the company's value lies in its patents and unique product, not in its scale.
%20of%20the%20company%20RxSight%20Inc.%20(RXST)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-RxSight-Inc.-RXST&v=1772574479027 "Chart of market capitalization per employee (in thousands of dollars) of the company RxSight Inc. (RXST)")
Market capitalization per employee (in thousands of dollars) in the market segment - Specialized medical equipment
RxSight has developed the first and only intraocular lens that is light-controlled after cataract surgery. In the MedTech sector, this figure represents a breakthrough technology. The chart shows how the market perceives the company's potential to change ophthalmology standards and improve the vision of millions of patients.
%20by%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Specialized-medical-equipment&v=1772574479178 "Market capitalization per employee (in thousands of dollars) by market segment - Specialized medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
RxSight, Inc. has developed intraocular lenses that can be adjusted after cataract surgery. This graph shows the high employee value typical of breakthrough medical technologies. The company's value is determined by its unique product, patents, and potential to change standards in ophthalmology.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772574479278 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company RxSight Inc. (RXST)
RxSight (RXST) is a medical technology company that has developed "light-tuned lenses" (LAL) for cataract surgery. After implantation, the doctor can "calibrate" the patient's vision with light. This chart shows how successfully the company is selling this premium technology. Revenue per employee depends on the adoption of this innovation by surgeons.
%20Chart%20RxSight%20Inc.%20(RXST)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-RxSight-Inc.-RXST&v=1772574479400 "Company Profit Per Employee (in thousands of dollars) Chart RxSight Inc. (RXST)")
Profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment
RxSight produces unique intraocular lenses (IOLs) that can be adjusted *after* cataract surgery using ultraviolet light. This is a breakthrough technology in ophthalmology. This chart shows how effectively the company is monetizing this innovation. It serves as a benchmark for assessing how successfully RxSight is selling its system to surgeons and patients.
%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Specialized-medical-equipment&v=1772574479509 "Chart of profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
RxSight (RXST) has developed and markets lenses (IOLs) that can be adjusted *after* cataract surgery (the Light Adjustable Lens). It's a revolutionary medical technology. This graph (loss-making) shows their path to commercialization. They spend heavily on R&D and surgeon training. Growth will begin when their expensive technology becomes standard treatment.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772574479539 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee RxSight Inc. (RXST)
RxSight has developed an intraocular lens whose curvature can be corrected after cataract surgery. This chart shows how the company is commercializing its unique medical technology. High revenue per employee is a result of selling a premium product.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-RxSight-Inc.-RXST&v=1772574479806 "Sales chart per company employee RxSight Inc. (RXST)")
Sales per employee in the market segment - Specialized medical equipment
RxSight has developed a lens (Light Adjustable Lens) implanted during cataract surgery that can be adjusted *after* the surgery. This graph shows the average revenue per employee in the segment. It demonstrates how productive their team is in promoting this unique technology among ophthalmologists.
Sales per employee for the market as a whole
RxSight is a medical device company that has developed a unique product—the "light-adjustable lens" (LAL). It's an intraocular lens (for cataract treatment) whose focus can be adjusted *after* surgery using UV light. It's like a "razor and a blade." This graph shows how their R&D and sales generate revenue from this breakthrough technology.
Short shares by company, segment and market as a whole
Shares shorted by company RxSight Inc. (RXST)
RxSight is a medical company that produces intraocular lenses (IOLs) for cataract surgery that can be adjusted *after* surgery. The bearish sentiment seen in this chart may be due to doubts about market acceptance. Bears are betting that this premium technology will be too expensive for widespread adoption.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-RxSight-Inc.-RXST&v=1772574479985 "Short Shares Chart for the Company RxSight Inc. (RXST)")
Shares shorted by market segment - Specialized medical equipment
RxSight is a manufacturer of intraocular lenses (IOLs) used in cataract surgery. Their lens is unique in that it can be "tuned" using UV light *after* surgery. This chart shows the overall sentiment in the sector. It reflects investor concerns that patients will postpone elective surgeries (like cataract surgery).
Shares shorted by the overall market
RxSight (RXST) produces intraocular lenses that can be adjusted *after* cataract surgery. It's a premium, largely elective procedure. This chart measures recession fears. As it rises, investors expect patients to choose cheaper standard lenses, abandoning RXST's expensive options.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator RxSight Inc. (RXST)
RxSight is a manufacturer of unique intraocular lenses (IOLs) that can be adjusted *after* cataract surgery. It's a breakthrough technology in ophthalmology. This chart measures how much investors believe in this technology. It shows when the stock is overbought due to hype or oversold due to fears of slow adoption.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-RxSight-Inc.-RXST&v=1772574480066 "RSI 14 indicator chart for the company's stock RxSight Inc. (RXST)")
RSI 14 Market Segment - Specialized medical equipment
RxSight is an ophthalmology innovator. They created the first and only intraocular lens (IOL) for cataract treatment whose diopter can be corrected *after* implantation using a dedicated UV device. This chart measures the overall momentum in the specialized medical device sector. It helps assess whether this entire niche segment is overheated.
RSI 14 for the overall market
RxSight (RXST) is a biotech company. Like everything in its sector, it's critically dependent on this chart. Market euphoria is an opportunity to easily raise hundreds of millions of dollars for research. Market panic is the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast RXST (RxSight Inc.)
RxSight (RXST) produces unique intraocular lenses (IOLs) that can be adjusted *after* cataract surgery using UV light. This chart shows the average target price. It reflects analysts' belief that this premium technology will be widely adopted by ophthalmic surgeons.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-RXST-RxSight-Inc.&v=1772574480331 "A chart showing analyst consensus forecasts for the expected stock price. RXST (RxSight Inc.)")
The difference between the consensus estimate and the actual stock price RXST (RxSight Inc.)
RxSight (RXST) is a medical technology company that has created a breakthrough. It produces the first and only intraocular lens (IOL) whose optics (diopters) can be adjusted AFTER cataract surgery. This chart shows the difference between the consensus estimate and the price, reflecting analysts' confidence in this unique technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-RXST-RxSight-Inc.&v=1772574480438 "A chart showing the difference between the consensus forecast and the actual stock price. RXST (RxSight Inc.)")
Analyst consensus forecast for stock prices by market segment - Specialized medical equipment
RxSight (RXST) is the company that developed the first and only light-activated intraocular lens (LAL). After implantation (for cataracts), it can be precisely "tuned" using UV light. This chart shows general expectations for the specialized medical equipment sector. It reflects whether experts believe there will be demand for this premium technology.
Analysts' consensus forecast for the overall market share price
RxSight is the medical device company behind the Light-Adjustable Lens (LAL), an intraocular lens (for cataracts) whose "diopters" can be adjusted *after* surgery using UV light. This chart shows the overall market sentiment. For RxSight, with its breakthrough technology, it's important to understand how these expectations (spending on "premium" medicine) influence its adoption. (350)
AKIMA index of the company, segment and market as a whole
AKiMA Company Index RxSight Inc.
RxSight is a medical technology innovator in ophthalmology. They created the Light Adjustable Lens (LAL), the first intraocular lens (IOL) that can be adjusted (changed in diopter) after cataract surgery. This chart is a barometer of their adoption. It likely reflects the rate of installation of their light-adjustable lenses in clinics and, more importantly, the sales volume of their premium, adjustable lenses.
AKIMA Market Segment Index - Specialized medical equipment
RxSight (RXST) is a revolutionary medtech company in ophthalmology; the company created the first (and only) intraocular lens (IOL) that can be adjusted (focused) using UV light AFTER cataract surgery. This composite metric evaluates companies. The graph shows the average value for the sector. This is the benchmark: how does this breakthrough (adjustable lens) model (RXST) differentiate itself from the average medtech competitor?
The AKIM Index for the overall market
RxSight is an ophthalmology company that created the first and only post-operatively adjustable intraocular lens (LAL). This chart, reflecting the market average, provides context. It helps assess how this premium MedTech company, dependent on patient spending, compares to overall macroeconomic trends.
